People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Akorn Inc | — | Pharmaceuticals | Seed | $3.8M | $63.4M | 2009 |
Michael P. Stehn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael P. Stehn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Subhash Kapre | 1 | 2 |
| Randall Wall | 1 | 1 |
| Ronald M. Johnson | 1 | 1 |
| Mark Silverberg | 1 | 1 |
| Jerry N. Ellis | 1 | 1 |
| Abu, Ph.D Alam | 1 | 1 |
| Jerry I. Treppel | 1 | 1 |
| Jeffrey A. Whitnell | 1 | 1 |
| Neill Shanahan | 1 | 1 |
| John R. Sabat | 1 | 1 |
| Sam, Ph.D Boddapati | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.